Presensitizing with a Toll-like receptor 3 ligand impairs CD8 T-cell effector differentiation and IL-33 responsiveness

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 26, 2012, Pages 10486-10491

  Ngoi, Soo Mun ^a   St Rose, Marie Clare ^a   Menoret, Antoine M ^a   Smith, Dirk E ^b   Tovey, Michael G ^c   Adler, Adam J ^a   Vella, Anthony T ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b AMGEN INC   (United States)

^c Ecole Normale Superieure de Cachan   (France)

Author keywords

Pathogen associated molecular patterns; Superantigens

Indexed keywords

CYTOKINE; CYTOKINE RECEPTOR; DOUBLE STRANDED RNA; INTERLEUKIN 33; POLYINOSINIC POLYCYTIDYLIC ACID; STAPHYLOCOCCUS ENTEROTOXIN; TOLL LIKE RECEPTOR 3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; IMMUNOREGULATION; INFLAMMATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SENSITIZATION; STAPHYLOCOCCUS AUREUS;

ANIMALS; ANTIGENS; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; INTERLEUKINS; LIGANDS; LYMPHOCYTE ACTIVATION; MICE; RNA, DOUBLE-STRANDED; TOLL-LIKE RECEPTOR 3;

MUS; STAPHYLOCOCCUS AUREUS;

EID: 84863004847     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1202607109     Document Type: Article

References (44)

1. Kawai T, Akira S (2008) Toll-like receptor and RIG-I-like receptor signaling. Ann N Y Acad Sci 1143:1-20.
2. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA (2001) Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413: 732-738. (Pubitemid 33009951)
3. Kato H, et al. (2006) Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441:101-105.
4. Currie AJ, et al. (2008) Targeting the effector site with IFN-alphabeta-inducing TLR ligands reactivates tumor-resident CD8 T cell responses to eradicate established solid tumors. J Immunol 180:1535-1544.
5. Schulz O, et al. (2005) Toll-like receptor 3 promotes cross-priming to virus-infected cells. Nature 433:887-892. (Pubitemid 40314900)
6. Kolumam GA, Thomas S, Thompson LJ, Sprent J, Murali-Krishna K (2005) Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J Exp Med 202:637-650. (Pubitemid 41248415)
7. Ngoi SM, Tovey MG, Vella AT (2008) Targeting poly(I:C) to the TLR3-independent pathway boosts effector CD8 T cell differentiation through IFN-alpha/beta. J Immunol 181:7670-7680.
8. Tough DF, Borrow P, Sprent J (1996) Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science 272:1947-1950. (Pubitemid 26234507)
9. Iwasaki A, Medzhitov R (2004) Toll-like receptor control of the adaptive immune responses. Nat Immunol 5:987-995. (Pubitemid 41057715)
10. Touil T, Fitzgerald D, Zhang GX, Rostami A, Gran B (2006) Cutting edge: TLR3 stimulation suppresses experimental autoimmune encephalomyelitis by inducing endogenous IFN-beta. J Immunol 177:7505-7509. (Pubitemid 44846263)
11. Yarilina A, DiCarlo E, Ivashkiv LB (2007) Suppression of the effector phase of inflammatory arthritis by double-stranded RNA is mediated by type I IFNs. J Immunol 178:2204-2211. (Pubitemid 46233418)
12. Serreze DV, Hamaguchi K, Leiter EH (1989) Immunostimulation circumvents diabetes in NOD/Lt mice. J Autoimmun 2:759-776.
13. Sobel DO, et al. (1998) Low dose poly I:C prevents diabetes in the diabetes prone BB rat. J Autoimmun 11:343-352. (Pubitemid 28428257)
14. Pinkse GG, et al. (2005) Autoreactive CD8 T cells associated with beta cell destruction in type 1 diabetes. Proc Natl Acad Sci USA 102:18425-18430. (Pubitemid 43011242)
15. Devendra D, et al. (2005) Interferon-alpha as a mediator of polyinosinic:polycytidylic acid-induced type 1 diabetes. Diabetes 54:2549-2556.
16. Ewel CH, Sobel DO, Zeligs BJ, Bellanti JA (1992) Poly I:C accelerates development of diabetes mellitus in diabetes-prone BB rat. Diabetes 41:1016-1021.
17. Moriyama H, et al. (2002) Induction and acceleration of insulitis/diabetes in mice with a viral mimic (polyinosinic-polycytidylic acid) and an insulin self-peptide. Proc Natl Acad Sci USA 99:5539-5544. (Pubitemid 34411584)
18. Sobel DO, et al. (1992) Poly I:C induces development of diabetes mellitus in BB rat. Diabetes 41:515-520.
19. Salem ML, Kadima AN, Cole DJ, Gillanders WE (2005) Defining the antigen-specific T-cell response to vaccination and poly(I:C)/TLR3 signaling: Evidence of enhanced primary and memory CD8 T-cell responses and antitumor immunity. J Immunother 28: 220-228. (Pubitemid 40593987)
20. Schmitz J, et al. (2005) IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23:479-490. (Pubitemid 41587888)
21. Iikura M, et al. (2007) IL-33 can promote survival, adhesion and cytokine production in human mast cells. Lab Invest 87:971-978. (Pubitemid 47429189)
22. Suzukawa M, et al. (2008) Interleukin-33 enhances adhesion, CD11b expression and survival in human eosinophils. Lab Invest 88:1245-1253.
23. Smithgall MD, et al. (2008) IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells. Int Immunol 20:1019-1030.
24. Bonilla WV, et al. (2012) The alarmin interleukin-33 drives protective antiviral CD8+ T cell responses. Science 335:984-989.
25. Yang Q, et al. (2011) IL-33 synergizes with TCR and IL-12 signaling to promote the effector function of CD8+ T cells. Eur J Immunol 41:3351-3360.
26. Lee SJ, et al. (2004) 4-1BB and OX40 dual costimulation synergistically stimulate primary specific CD8 T cells for robust effector function. J Immunol 173:3002-3012.
27. Bachert C, Gevaert P, van Cauwenberge P (2002) Staphylococcus aureus superantigens and airway disease. Curr Allergy Asthma Rep 2:252-258.
28. Muralimohan G, Rossi RJ, Guernsey LA, Thrall RS, Vella AT (2008) Inhalation of Staphylococcus aureus enterotoxin A induces IFN-gamma and CD8 T cell-dependent airway and interstitial lung pathology in mice. J Immunol 181:3698-3705.
29. Arad G, Hillman D, Levy R, Kaempfer R (2001) Superantigen antagonist blocks Th1 cytokine gene induction and lethal shock. J Leukoc Biol 69:921-927. (Pubitemid 32577893)
30. Kurowska-Stolarska M, et al. (2008) IL-33 induces antigen-specific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4. J Immunol 181: 4780-4790.
31. Stolarski B, Kurowska-Stolarska M, Kewin P, Xu D, Liew FY (2010) IL-33 exacerbates eosinophil-mediated airway inflammation. J Immunol 185:3472-3480.
32. Liu X, et al. (2009) Anti-IL-33 antibody treatment inhibits airway inflammation in a murine model of allergic asthma. Biochem Biophys Res Commun 386:181-185.
33. Marshall HD, Urban SL, Welsh RM (2011) Virus-induced transient immune suppression and the inhibition of T cell proliferation by type I interferon. J Virol 85:5929-5939.
34. Wilson NS, et al. (2006) Systemic activation of dendritic cells by Toll-like receptor ligands or malaria infection impairs cross-presentation and antiviral immunity. Nat Immunol 7:165-172. (Pubitemid 43135882)
35. Bahl K, Huebner A, Davis RJ, Welsh RM (2010) Analysis of apoptosis of memory T cells and dendritic cells during the early stages of viral infection or exposure to Toll-like receptor agonists. J Virol 84(10):4866-4877.
36. Marshall HD, Prince AL, Berg LJ, Welsh RM (2010) IFN-alpha beta and self-MHC divert CD8 T cells into a distinct differentiation pathway characterized by rapid acquisition of effector functions. J Immunol 185(3):1419-1428.
37. Aumeunier A, et al. (2010) Systemic Toll-like receptor stimulation suppresses experimental allergic asthma and autoimmune diabetes in NOD mice. PLoS ONE 5: e11484.
38. Peres A, Amlani S, Kornbluth M, Seemayer TA, Lapp WS (1989) The effects of polyinosinic: polycytidylic acid on the graft-versus-host reaction. III: Increased severity of the reaction with delayed pI:C treatment. Transplantation 48:80-84. (Pubitemid 19194043)
39. Peres A, Seemayer TA, Lapp WS (1986) The effects of polyinosinic: polycytidylic acid (pI:C) on the GVH reaction: Immunopathological observations. Clin Immunol Immunopathol 39:102-111. (Pubitemid 16127334)
40. Balasubramani A, et al. (2010) Modular utilization of distal cis-regulatory elements controls Ifng gene expression in T cells activated by distinct stimuli. Immunity 33:35-47.
41. Yang J, Zhu H, Murphy TL, Ouyang W, Murphy KM (2001) IL-18-stimulated GADD45 beta required in cytokine-induced, but not TCR-induced, IFN-gamma production. Nat Immunol 2:157-164. (Pubitemid 33707936)
42. Borish L, Steinke JW (2011) Interleukin-33 in asthma: How big of a role does it play? Curr Allergy Asthma Rep 11:7-11.
43. Jung YW, Zindl CL, Lai JF, Weaver CT, Chaplin DD (2009) MMP induced by Gr-1+ cells are crucial for recruitment of Th cells into the airways. Eur J Immunol 39:2281-2292.
44. Palmer G, et al. (2009) Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis. Arthritis Rheum 60:738-749.